drugs
Samsung completes hat-trick of big biosimilar approvals
August 25, 2017Medical Communications, Sales and Marketing Biogen, Samsung Bioepis, biosimilars, biotech, drugs, pharma, pharmaceutical
Samsung Bioepis has announced that it, alongside its partner Biogen, has secured European Commission approval for its biosimilar version of …
‘Trade secret information’ to be shared between EMA and FDA
August 25, 2017Manufacturing and Production, Medical Communications EMA, FDA, biotech, drugs, pharma, pharmaceutical
As part of the on-going harmonisation of manufacturing standards across the Atlantic, the EMA and FDA have announced that they …
Roche receives FDA Priority Review for drug with potted history
August 24, 2017Sales and Marketing Roche, biotech, drugs, emicizumab, pharma, pharmaceutical
Roche, alongside its subsidiary, Genentech, announced that it has received Priority Review for its haemophilia A drug, emicizumab, and that …
HIV home tests seized from market over potential risk
August 24, 2017Sales and Marketing HIV, MHRA, biotech, drugs, pharma, pharmaceutical
The MHRA has removed over 100 HIV home testing kits from two UK based suppliers, after they were found not …
Novartis gets EU nod for potential blockbuster breast cancer drug
August 24, 2017Sales and Marketing CDK4/6, Novartis, biotech, breast cancer, drugs, pharma, pharmaceutical
Novartis has released that it has received marketing approval from the European Commission for its drug for the treatment of …
Collaboration between Lilly and CRUK progresses to clinical trials
August 23, 2017Research and Development Cancer Research UK, biotech, drugs, pharma, pharmaceutical
Cancer Research UK has announced that its collaboration with Eli Lilly for the treatment of advanced solid tumours will progress …
Scientists discover ‘Achilles’ heel’ of oesophageal cancer
August 23, 2017Research and Development ICR, Janssen, biotech, drugs, pharma, pharmaceutical
Researchers from The Institute of Cancer Research have potentially found a new use for Imbruvica, after discovering a weakness in …
Ultragenyx stumbles in P3 trial for severe muscle disease
August 23, 2017Research and Development Ultragenyx, biotech, drugs, pharma, pharmaceutical
Ultragenyx has revealed results from a Phase 3 trial into the treatment of GNE myopathy showed that its compound did …
Hikma risks a stratospheric 430% price increase on product
August 22, 2017Manufacturing and Production, Sales and Marketing Hikma, biotech, drugs, generics, pharma, pharmaceutical
It wasn’t so long ago that pharmaceutical companies could change the prices of its products with little scrutiny. A series …
Outcry after private hospitals receive tax breaks instead of NHS
August 22, 2017Manufacturing and Production, Medical Communications NHS, biotech, drugs, pharma, pharmaceutical
It has been revealed that private hospitals being run across England and Wales will receive £52 million in tax breaks …
Taking science and making people feel connected to it
August 21, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, biotech, drugs, pharma, pharmaceutical, rare diseases
Owen Marks, Country Head for the Rare Disease Unit at Pfizer UK, discusses his career so far and what drives …
Antibacterial power of mother’s milk revealed
August 21, 2017Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical
Researchers from Vanderbilt University have discovered a previously unknown ability of a compound in mother’s milk to protect new-borns from …
Samsung Bioepis collaborates to make inroads into original drugs
August 21, 2017Research and Development, Sales and Marketing Samsung Bioepis, Takeda, biotech, drugs, pharma, pharmaceutical
Thus far, Samsung Bioepis has made its name by being a thorn in the side of the producers of original …
Novartis begins ‘next-generation’ malaria treatment trial
August 21, 2017Research and Development, Sales and Marketing MMV, Novartis, biotech, drugs, malaria, pharma, pharmaceutical
Novartis, alongside Medicines for Malaria Venture (MMV), have revealed that trials into a new antimalarial compound have begun in a …
The pendulum swing of generic drug prices
August 18, 2017Medical Communications biotech, drugs, generics, pharma, pharmaceutical
The prices of generic drugs have been driven lower as companies compete to undercut one another. This has led to …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
